Matthew Milowsky
Section Chief of the Genitourinary Oncology Service · UNC School of Medicine
Credentials: · · ·
History
PresentGenitourinary Oncology Service Section · UNC School of Medicine
- Present
Urologic Oncology Program · UNC School of Medicine
New York Presbyterian Hospital—Weill Cornell Medical Center
New England Medical Center—Tufts University School of Medicine
- 1996
State University of New York (SUNY) Downstate College of Medicine
Research
Adjuvant Nivolumab versus Placebo in Muscle-Invasive Urothelial Carcinoma
New England Journal of Medicine · 2021 · 864 citations
Intrinsic subtypes of high-grade bladder cancer reflect the hallmarks of breast cancer biology
Proceedings of the National Academy of Sciences of the United States of America · 2014 · 719 citations
Genome sequencing identifies a basis for everolimus sensitivity
Science · 2012 · 555 citations
42 papers
- DB
38 papers
32 papers
31 papers
28 papers
22 papers
- JR
22 papers
21 papers
Grants
- 1997–2027
National Cancer Institute · P30
Project lead · $344.8K · Univ of North Carolina Chapel Hill
- 2019–2027
UNC Lead Academic Participating Site
National Cancer Institute · UG1
PI · $3.5M · Univ of North Carolina Chapel Hill
Clinical trials
- 2023–2025
ctDNA in Subjects With Muscle-invasive Bladder Cancer Treated With Trimodality Therapy
Principal investigator · Completed
UNC Lineberger Comprehensive Cancer Center
- 2022–2025
Principal investigator · Completed · Phase 2
UNC Lineberger Comprehensive Cancer Center
- 2016–2026
Phase 2 Study of Pembrolizumab in Combination With Gemcitabine and Cisplatin as Neoadjuvant Therapy
Principal investigator · Completed · Phase 2
UNC Lineberger Comprehensive Cancer Center
- 2015–2017
Principal investigator · Terminated · Phase 2
UNC Lineberger Comprehensive Cancer Center